Arrowstreet Capital’s Acceleron Pharma Inc. XLRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-9,018
| Closed | -$1.13M | – | 1997 |
|
2021
Q2 | $1.13M | Buy |
+9,018
| New | +$1.13M | ﹤0.01% | 1503 |
|
2021
Q1 | – | Sell |
-126,533
| Closed | -$16.2M | – | 2663 |
|
2020
Q4 | $16.2M | Buy |
126,533
+23,721
| +23% | +$3.03M | 0.02% | 671 |
|
2020
Q3 | $11.6M | Buy |
102,812
+78,512
| +323% | +$8.83M | 0.02% | 772 |
|
2020
Q2 | $2.32M | Buy |
+24,300
| New | +$2.32M | ﹤0.01% | 1417 |
|
2017
Q4 | – | Sell |
-12,000
| Closed | -$448K | – | 1436 |
|
2017
Q3 | $448K | Buy |
+12,000
| New | +$448K | ﹤0.01% | 950 |
|
2016
Q4 | – | Sell |
-5,700
| Closed | -$206K | – | 2710 |
|
2016
Q3 | $206K | Buy |
+5,700
| New | +$206K | ﹤0.01% | 1418 |
|